WuXi NextCODE has acquired GM Medicine Ireland ( uk ) , as part of a wider $ 400 m initiative aimed at promoting Ireland as a global hub for genomic research and advanced life sciences . The Ireland Strategic Investment Fund has contributed $ 70 m to the investment , while other investors include ARCH investment Partners , Polaris ventures , Temasek , Yunfeng ventures and Sequoia Capital . Financial terms of the GMI acquisition were not disclosed .
WuXi NextCODE has acquired Genomics Medicine Ireland (GMI), as part of a wider $400m initiative aimed at promoting Ireland as a global hub for genomic research and advanced life sciences. The Ireland Strategic Investment Fund has contributed $70m to the investment, while other investors include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital. Financial terms of the GMI acquisition were not announced.